Design of inhibitors of thymidylate kinase from Variola virus as new selective drugs against smallpox

European Journal of Medicinal Chemistry

Volumn 91, Issue , 2015, Pages 72-90

  Guimarães, Ana P ^a,b   De Souza, Felipe R ^b   Oliveira, Aline A ^c   Gonçalves, Arlan S ^d   De Alencastro, Ricardo B ^e   Ramalho, Teodorico C ^f   França, Tanos C C ^b  

^a FEDERAL UNIVERSITY OF VIÇOSA   (Brazil)

^b MILITARY INSTITUTE OF ENGINEERING   (Brazil)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

^d Campus Serra   (Brazil)

^e FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^f FEDERAL UNIVERSITY OF LAVRAS   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; ACICLOVIR; ANTIVIRUS AGENT; CIDOFOVIR; GANCICLOVIR; LAMIVUDINE; NELARABINE; RIBAVIRIN; STAVUDINE; TENOFOVIR; THYMIDYLATE KINASE INHIBITOR; TRIFLURIDINE; UNCLASSIFIED DRUG; VALACICLOVIR; VALGANCYCLOVIR; ZIDOVUDINE; CYTOSINE; DTMP KINASE; LIGAND; MOLECULAR LIBRARY; NUCLEOSIDE MONOPHOSPHATE KINASE; PHOSPHONIC ACID DERIVATIVE; VIRUS PROTEIN;

ARTICLE; CONTROLLED STUDY; DRUG BINDING; DRUG DESIGN; DRUG POTENCY; DRUG SELECTIVITY; DRUG STRUCTURE; MOLECULAR DOCKING; MOLECULAR DYNAMICS; NONHUMAN; SIMULATION; SMALLPOX; SMALLPOX VIRUS; ANALOGS AND DERIVATIVES; ANTAGONISTS AND INHIBITORS; CHEMISTRY; ENZYME ACTIVE SITE; ENZYMOLOGY; GENETICS; HUMAN; KINETICS; MOLECULAR LIBRARY; MUTATION; SPECIES DIFFERENCE; STRUCTURE ACTIVITY RELATION; THERMODYNAMICS; VIROLOGY;

ACYCLOVIR; ANTIVIRAL AGENTS; CATALYTIC DOMAIN; CYTOSINE; DRUG DESIGN; HUMANS; KINETICS; LIGANDS; MOLECULAR DOCKING SIMULATION; MOLECULAR DYNAMICS SIMULATION; MUTATION; NUCLEOSIDE-PHOSPHATE KINASE; ORGANOPHOSPHONATES; SMALL MOLECULE LIBRARIES; SMALLPOX; SPECIES SPECIFICITY; STRUCTURE-ACTIVITY RELATIONSHIP; THERMODYNAMICS; VARIOLA VIRUS; VIRAL PROTEINS;

EID: 84921515895     PISSN: 02235234     EISSN: 17683254     Source Type: Journal    
DOI: 10.1016/j.ejmech.2014.09.099     Document Type: Article

References (46)

1. N. Paran G. Sutter Smallpox vaccines: new formulations and revised strategies for vaccination Hum. Vaccine 12 2009 824 831
2. B. Moss Smallpox vaccines: targets of protective immunity Immunol. Rev. 239 2011 8 26
3. B. Moss Poxviridae: the viruses and their replication D.M. Knipe Fields Virology fifth ed. 2007 Lippincott Williams & Wilkins Philadelphia 2905 2946
4. R.S. Essbaue M. Pfeffer H. Meyer Zoonotic poxviruses Vet. Microbiol. 140 2010 229 236
5. G.J. Harper Airborne micro-organisms: survival tests with four viruses J. Hyg. 59 1961 479 486
6. F. Huq Effect of temperature and relative humidity on variola virus in crusts Bull. World Health Organ 54 1976 710 712
7. N. Chen G. Li M.K. Liszewski J.P. Atkinson P.B. Jahrling Z. Feng J. Schriewer C. Wang E.J. Lefkowitz J.J. Esposito T. Harms I.K. Damon R.L. Roper C. Upton R.M. Buller Virulence differences between monkeypox virus isolates from West Africa and the Congo basin Virology 340 2005 46 63
8. D.S. Sambyal B.B. Verma K.K. Baxi A note on an outbreak of cowpox at Taran Taran. Amritsar (Punjab) Indian Vet. J. 60 1983 327 328
9. F.G. da Fonseca E.G. Kroon M.L. Nogueira G.S. Trindade Zoonotic vaccinia virus outbreaks in Brazil Future Virol. 6 2011 697 707
10. D. Alzhanova K. Früh Modulation of the host immune response by cowpox virus Microbes Infect. 12 2010 900 909
11. H. Campe P. Zimmermann K. Glos M. Bayer H. Bergemann C. Dreweck P. Graf B.K. Weber H. Meyer M. Büttner U. Busch A. Sing Cowpox virus transmission from pet rats to humans, Germany Emerg. Infect. Dis. 15 2009 777 780
12. C.S. Johnston K.L. Lin J.H. Connor G. Ruthel A. Goff L.E. Hensley In vitro inhibition of monkeypox virus production and spread by Interferon-β Virol. J. 9 2012 1 15
13. K. Mätz-Rensing H. Ellerbrok B. Ehlers G. Pauli A. Floto M. Alex C.P. Czerny F.J. Kaup Fatal poxvirus outbreak in a colony of new world monkeys Vet. Pathol. 43 2006 212 218
14. L. Ninove Y. Domart C. Vervel C. Voinot N. Salez D. Raoult H. Meyer I. Capek C. Zandotti R.N. Charrel Cowpox virus transmission from pet rats to humans, France Emerg. Infect. Dis. 15 2009 781 784
15. G. Schmiedeknecht M. Eickmann K. Mköhler C.E. Herden L. Kolesnikova C. Förster E.H. Burkhardt M. Köhler M. Thiel M. Reinacher Fatal cowpox virus infection in captive banded mongooses (Mungos mungo) Vet. Pathol. 47 2010 47 552
16. R.O. Baker M. Bray J.W. Huggins Potential antiviral therapeutics for smallpox, monkeypox and other orthopoxvirus infections Antivir. Res. 57 2003 13 23
17. R.M. Vorou V.G. Papavassiliou I.N. Pierroutsakos Cowpox virus infection: an emerging health threat Curr. Opin. Infect. Dis. 21 2008 153 156
18. D. Baxby M. Bennett Cowpox: a re-evaluation of the risks of human cowpox based on new epidemiological information Arch. Virol. Suppl. 13 1997 1 12
19. M.G. Reynolds K.L. Yorita M.J. Kuehnert W.B. Davidson G.D. Huhn R.C. Holman I.K. Damon Clinical manifestations of human monkeypox influenced by route of infection J. Infect. Dis. 194 2006 773 780
20. L. Randley R.M. Buller S.E. Frey C. Bellone S. Parker The new ACAM2000 vaccine and other therapies to control orthopoxvirus outbreaks and bioterror attacks Expert Rev. Vaccines 8 2009 841 850
21. R.B. Kennedy I.G. Ovsyannikova R.M. Jacobson G.A. Poland The immunology of smallpox vaccines Curr. Opin. Immunol. 21 2009 314 320
22. C.M. Byrd T.C. Bolken A.M. Mjalli M.N. Arimilli R.C. Andrews R. Rothlein T. Andrea M. Rao K.L. Owens D.E. Hruby New class of orthopoxvirus antiviral drugs that block viral maturation J. Virol. 78 2004 12147 12156
23. E. De Clercq Antivirals and antiviral strategies Nat. Rev. Microbiol. 2 2004 704 720
24. M. Bray Pathogenesis and potential antiviral therapy of complications of smallpox vaccination Antivir. Res. 58 2003 101 114
25. K.C. Cundy Clinical pharmacokinetics of the antiviral nucleotide analogues cidofovir and adefovir Clin. Pharmacokinet. 36 1999 127 143
26. K.Y. Hostetler Synthesis and early development of hexadecyloxypropylcidofovir: an oral antipoxvirus nucleoside phosphonate Viruses 2 2010 2213 2225
27. A.P. Guimarães T.C. Ramalho T.C. França Preventing the return of smallpox: molecular modeling studies on thymidylate kinase from Variola virus Biomol. Struct. Dyn. 32 2014 1601 1612
28. D.S. Wishart C. Knox A.C. Guo D. Cheng S. Shrivastava D. Tzur B. Gautam M. Hassanali DrugBank: a knowledgebase for drugs. drug actions and drug targets Nucleic Acids Res. 36 Database issue 2008 D901 D906
29. C. Knox V. Law T. Jewison P. Liu S. Ly A. Frolkis A. Pon K. Banco C. Mak V. Neveu Y. Djoumbou R. Eisner A.C. Guo D.S. Wishart DrugBank 3.0: a comprehensive resource for 'omics' research on drugs Nucleic Acids Res. 39 Database issue 2011 D1035 D1041
30. H.M. Berman J. Westbrook Z. Feng G. Gilliland T.N. Bhat H. Weissig I.N. Shindyalov P.E. Bourne The protein data bank Nucleic. Acids. Res. 28 2000 235 242
31. W.J. Hehre B.J. Deppmeier P.E. Klunzinger PC SPARTAN Pro 1999 Wavefunction, Inc Irvine, CA
32. G.B. Rocha R.O. Freire A.M. Simas J.J. Stewart RM1: a reparameterization of AM1 for H, C, N, O, P, S, F, Cl, Br, and I J. Comput. Chem. 27 2006 1101 1111
33. R. Thomsen M.H. Christensen MolDock: a new technique for high accuracy molecular docking J. Med. Chem. 49 2006 3315 3332
34. C. Oostenbrink A. Villa A.E. Mark W.F. Van Gunsteren A biomolecular force field based on the free enthalpy of hydration and solvation: the GROMOS force-field parameter sets 53A5 and 53A6 J. Comput. Chem. 25 2004 1656 1676
35. B. Hess C. Kutzner D. Van der Spoel E. Lindahl GROMACS 4: algorithms for highly efficient, load-balanced, and scalable molecular simulation J. Chem. Theo. Comput. 4 2008 435 447
36. A.P. Guimarães A.A. Oliveira E.F.F. da Cunha T.C. Ramalho T.C.C. França Design of new chemotherapeutics against the deadly anthrax disease. Docking and molecular dynamics studies of inhibitors containing pyrrolidine and riboamidrazone rings on nucleoside hydrolase from J. Biomol. Struct. Dyn. 28 2011 455 469
37. A.P. Guimarães A.A. Oliveira E.F.F. da Cunha T.C. Ramalho T.C.C. França Analysis of Bacillus anthracis nucleoside hydrolase via in silico docking with inhibitors and molecular dynamics simulation J. Mol. Mod. 17 2011 2939 2951
38. D.M. Van Aalten R. Bywater J.B. Findlay M. Hendlich R.W. Hooft G. Vriend J. Comput. Aid. Mol. Des. 10 1996 255 262
39. C.M. Breneman K.B. Wiberg Determining atom-centered monopoles from molecular electrostatic potentials. The need for high sampling density in formamide conformational analysis J. Comput. Chem. 11 1990 361 373
40. M.J. Frisch G.W. Trucks H.B. Schlegel G.E. Scuseria M.A. Robb J.R. Cheeseman J.A. Montgomery T. Vreven K.N. Kudin J.C. Burant J.M. Millam S.S. Iyengar J. Tomasi V. Barone B. Mennucci M. Cossi G. Scalmani N. Rega G.A. Petersson H. Nakatsuji M. Hada M. Ehara K. Toyota R. Fukuda J. Hasegawa M. Ishida T. Nakajima Y. Honda O. Kitao H. Nakai M. Klene X. Li J.E. Knox H.P. Hratchian J.B. Cross V. Bakken C. Adamo J. Jaramillo R. Gomperts R.E. Stratmann O. Yazyev A.J. Austin R. Cammi C. Pomelli J.W. Ochterski P.Y. Ayala K. Morokuma G.A. Voth P. Salvador J.J. Dannenberg V.G. Zakrzewski S. Dapprich A.D. Daniels M.C. Strain O. Farkas D.K. Malick A.D. Rabuck K. Raghavachari J.B. Foresman J.V. Ortiz Q. Cui A.G. Baboul S. Clifford J. Cioslowski B.B. Stefanov G. Liu A. Liashenko P. Piskorz I. Komaromi R.L. Martin D.J. Fox T. Keith M.A. Al-Laham C.Y. Peng A. Nanayakkara M. Challacombe P.M.W. Gill B. Johnson W. Chen M.W. Wong C. Gonzalez J.A. Pople Gaussian 03 2004 Gaussian. Inc Wallingford. CT
41. P. Hohenberg W. Kohn Inhomogeneous electron gas Phys. Rev. B 136 1964 864 871
42. U. Essmann L. Perera M.L. Berkowitz T. Darden H. Lee L.G. Pedersen A smooth particle Mesh Ewald method J. Chem. Phys. 103 1995 8577 8592
43. W. Humphrey A. Dalke K. Schulten VMD: visual molecular dynamics J. Mol. Graph. 14 1996 33 38
44. N. Guex M.C. Peitsch SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modeling Electrophoresis 18 1997 2714 2723
45. P.M. Edwards Origin 7.0: scientific graphing and data analysis software J. Chem. Inf. Comput. Sci. 42 2002 1270 1271
46. D. Warren The PyMOL Molecular Graphics System 2002 DeLano Scientific San Carlos, CA